Teams of doctors at Harvard Medical School, Cambridge University in England and elsewhere are studying the effect of Ateronon, a compound which provides the antioxidant properties of a Mediterranean diet. It is believed that Ateronon will provide a supplement formula free from side-effects.
Lycopene, the key ingredient in Ateronon, is a well-know antioxidant derived from tomatoes. Antioxidants block the breakdown of fats in the blood which leads to fat deposits on artery walls. By combining lycopene with a lactose-based milk protein, Ateronon has lycopene molecules small enough to be easily absorbed by humans.
A bio-technology spin-off company of Cambridge University, CTL, states that treatment with Ateronon can not only halt, but also reverse the build up of arterial fat in as little as eight weeks. “We are confident that Ateronon will show quite dramatic benefits in patients with heart and circulatory disorders…,” says Dr. Gunter Schmidt, the chief executive of CTL.
